CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
CVRx, Inc. (CVRX)
Company Research
Source: GlobeNewswire
MINNEAPOLIS, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the fourth quarter and full year of 2023, and affirmed its 2024 business outlook. Recent Highlights Total revenue for the fourth quarter of 2023 was $11.3 million, an increase of 58% over the prior year quarterU.S. Heart Failure (HF) revenue for the fourth quarter of 2023 was $10.2 million compared to $6.0 million in the prior year quarter, an increase of 70% over the prior year quarterTotal revenue for 2023 was $39.3 million, an increase of 75% over the prior yearActive implanting centers for 2023 increased to 178, a 68% increase since December 31, 2022As previously announced, President and CEO Nadim Yared plans to retire upon the completion of a deliberate succession process and th
Show less
Read more
Impact Snapshot
Event Time:
CVRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVRX alerts
High impacting CVRx, Inc. news events
Weekly update
A roundup of the hottest topics
CVRX
News
- CVRx, Inc. (NASDAQ: CVRX) had its price target lowered by analysts at Lake Street Capital from $35.00 to $18.00. They now have a "buy" rating on the stock.MarketBeat
- Investigation Into CVRx, Inc. (CVRX) Announced by Holzer & Holzer, LLCGlobeNewswire
- CVRx, Inc. (NASDAQ: CVRX) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $32.00 to $14.00. They now have a "buy" rating on the stock.MarketBeat
- CVRx stock plunges 42% in wake of Q1 report, updated forecast [Seeking Alpha]Seeking Alpha
- CVRx, Inc. (NASDAQ:CVRX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
CVRX
Earnings
- 4/30/24 - Miss
CVRX
Sec Filings
- 4/30/24 - Form 8-K
- 4/23/24 - Form DEFA14A
- 4/23/24 - Form DEF
- CVRX's page on the SEC website